Key result
This paper is a study protocol for a randomized clinical trial and does not contain results.
Why the study?
Little is known regarding the effect of autonomic nervous system activation on flow-mediated dilation of the brachial artery in response to different exercise types in hypertensive individuals.
Does doxazosin improve flow-mediated dilation of the brachial artery in response to acute exercise in hypertensive individuals?
RCT (n=39)
Double-blind
Simple randomization via computer program
No
Does doxazosin improve flow-mediated dilation of the brachial artery in response to acute exercise in hypertensive individuals?
This study protocol outlines a randomized trial to evaluate whether autonomic nervous system activation, modulated by an alpha-1 adrenergic blocker, affects endothelial function in response to acute exercise in hypertensive individuals.
Answers are grounded in this paper and cite their sources.
Protocol for RCT testing doxazosin on exercise-induced FMD in hypertension; leaves open autonomic effects on endothelial function until results emerge.
Background: Arterial hypertension has a direct association with endothelial dysfunction and major cardiovascular events. There is evidence showing the benefits of aerobic exercise on flow-mediated dilation (FMD) in hypertensive individuals but little is known about the effect of autonomic nervous system (ANS) activation on FMD of the brachial artery in response to different types of exercise in this specific population. This study aims to examine the effects of ANS activation on FMD of the brachial artery in response to exercise in hypertensive individuals following a session of different types of exercise including aerobic exercise (AE), resistance exercise (RE) or combined exercise (CE). Methods: Thirty-nine hypertensive volunteers aged 35 to 55 years will be randomly assigned to two exercise sessions: AE (40 minutes on a cycle ergometer at 60% of HR reserve); RE (4 lower limb sets with 12 repetitions at 60% 1-RM for 40 minutes) or CE (RE for 20 minutes + AE for 20 minutes). Each exercise group will be randomized to receive either an α1-adrenergic blocker (doxazosin 0.05 mg/kg-1) or placebo. Ultrasound measurement of FMD is performed 10 minutes before and 10, 40 and 70 minutes after exercise. ANS activation is monitored using a Finometer and measurements are taken during 10 minutes before each FMD assessment. Arterial stiffness is assessed by pulse wave velocity (PWV) analysis using a Complior device. Discussion: We expect to demonstrate the effect of ANS activation on FMD of the brachial artery in hypertensive individuals in response to different types of exercise. This study may give some insight on how to improve exercise prescription for hypertension management. Trial registration: www.clinicaltrials.gov (ID: NCT04371757).
No takes yet. Share an insight, caveat, or question.
Waclawovsky et al. (2020) conducted an RCT in Arterial hypertension (n=39). Doxazosin (α1-adrenergic blocker) prior to acute exercise vs. Placebo was evaluated on Flow-mediated dilation (FMD) of the brachial artery. This paper is a study protocol for a randomized clinical trial and does not contain results.
Synapse has enriched 10 related papers. Consider them for comparative context: